Back to Journals » Drug Design, Development and Therapy » Volume 12

Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure

Total article views   HTML views PDF downloads Totals
16,798 Dovepress* 15,000+ 1,011 16,011
PubMed Central* 1,798 307 2,105
Totals 16,798 1,318 18,116
*Since 10 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar